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Background: Tumor microenviroment is characteristic of inflammation, ischemia and starvation of nutrient. TNF-α,
which is an extraordinarily pleiotropic cytokine, could be an endogenous tumor promoter in some tumor types.
The basic objective of this study was to investigate the effects of TNF-α on the cell viability and apoptosis of
hepatocellular carcinoma cells under serum starvation, and to identify the molecular mechanisms involved.
Methods: For this purpose, five different concentrations of TNF-α and two different serum settings (serum-cultured
and serum-deprived) were used to investigate the effects of TNF-α on the cell viability and apoptosis of Hep3B and
SMMC-7721 cells.
Results: TNF-α (10 ng/ml) attenuated serum starvation-induced apoptosis of hepatocellular carcinoma cells, and
autophagy conferred this process. BAY11-7082, a specific inhibitor of NF-κB, reversed the suppression of serum
starvation-induced apoptosis by TNF-α. Moreover, TNF-α-induced NF-κB transactivation was suppressed by autophagy
inhibitor 3-MA. In addition, TNF-α up-regulated Ferritin heavy chain (FHC) transiently by NF-κB activation and FHC levels
were correlated with the TNF-α-induced protection against serum starvation-mediated apoptosis of hepatocellular
carcinoma cells. Furthermore, FHC-mediated inhibition of apoptosis depended on suppressing ROS accumulation.
Conclusions: Our findings suggested that autophagy conferred the TNF-α protection against serum
starvation-mediated apoptosis of hepatocellular carcinoma cells, the mechanism involved with the activation of
the TNF-α/ NF-κB /FHC signaling pathway.
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Many experimental evidence indicates that TNF-α is as-
sociated with the survival of cancer cells [1,2]. TNF-α-
mediated the killing of certain cancer cells has been
demonstrated [3,4]. Although TNF-α itself was named
for its ability to induce cell death, it has been known
that TNF-α stimulation also can induce activation of the* Correspondence: weilixin@yahoo.com; wumengchao2012@126.com
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reproduction in any medium, provided the ortranscription factor NF-κB [5-8]. Many normal cells are
not killed by TNF-α and this may be related to NF-κB
transactivation; blockade of NF-κB sensitizes cells to
TNF-α and augments induced apoptotic cell death [9].
TNF-α induced NF-κB transactivation through the path-
way of IκB kinase complex phosphorylation, degradation
of IκBα and release of cytoplasm-sequestered [10]. TNF-
α-induced NF-κB transactivation is mainly composed of
a hetero-dimer of p65 (RelA) and a p50 subunits. NF-κB
transactivation can activate expression of a wide variety
of genes including the Ferritin heavy chain [11,12]. Recent
studies have shown that NF-κB-regulated FHC can inhibit
caspase activity and can prevent TNF-α-induced apoptosis. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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IAP genes sensitized endothelial cells to TNF-α-induced
apoptosis. We have previously shown that Hep3B and
SMMC-7721 cells are resistant to serum starvation-
induced cell death due to activation of NF-κB by TNF-α.
In the present study, we show that serum starvation in-
duced significant apoptosis in the Hep3B and SMMC-7721
cells, and this cell death was attenuated by pre-incubation
of TNF-α via suppression of caspase activation and coin-
cident with Ferritin heavy chain up-regulation. Inhibition
of NF-κB transactivation using a pharmacological in-
hibitor of IKK abrogated the TNF-α-induced protec-
tion against serum starvation killing. We demonstrate
that temporal TNF-α-mediated suppression of serum
starvation-mediated apoptosis may be due to the transient
up-regulation of FHC by TNF-α.
Methods
Cell culture and regent
Human hepatocellular carcinoma cell lines Hep3B and
SMMC-7721 were purchased from Cell Bank of Type
Culture Collection of Chinese Academy of Sciences,
Shanghai Institute of Cell Biology, Chinese Academy of
Sciences. Human hepatocellular carcinoma cell lines
Hep3B and SMMC-7721 were cultured at 37°C, with 5%
CO2, in Dulbecco’s modified Eagle’s medium (high glu-
cose) (GIBCO, Invitrogen) with 10% fetal bovine serum,
supplemented with 2 mM L-glutamine, 100 U/ml penicil-
lin, and 100ug/ml streptomycin. Cells were subcultured
every 3 days when they reached 70%-80% confluence. 3-
Methyladenine (3-MA, Sigma-Aldrich) was dissolved in
heated sterile double distilled water to make a 400 mM
stock solution and then added to the medium after heating
for a final concentration of 5 mM.
Western blot analysis
Total protein was extracted from cells using lysis buffer
and the protein concentrations were measured by BCA
protein assay. The cell lysates were loaded on SDS-PAGE,
electrophoresed and transferred onto the PVDF mem-
branes. The membranes were blocked in 5% non-fat dry
milk in 0.01% Tween/PBS, incubated in primary antibody
overnight at 4°C, then incubated in HRP-conjugated sec-
ondary antibodies and developed using ECL plus detection
reagent. The primary antibodies used in this study are:
P62 (#5114, Cell Signaling Technology), LC3 (#4108,
Cell Signaling Technology), IκBα (#4812, Cell Signaling
Technology), P65 (sc-8008, Santa Cruz Biotechnology,
Inc), Cleaved caspase-3 (ab52293, Abcam), Caspase-8
(AP0358, Bioworld), FHC (ab65080, Abcam).
MTT assay
3-(4,5-dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium brom-
ide assay (Sigma Aldrich) was used to determine cellsurvival. Cell count was adjusted to 1 × 104 cells/ml 100 μl
of cells suspension was plated in each well of 96-well plate.
At the end of the various treatment, the medium was re-
moved and cells were immediately washed with PBS, then
150 μl/well of MTT solution was added. After 3 h, media
containing MTT was removed and 100 μl of DMSO was
added to each well to dissolve the formazan crystals. Ab-
sorbance was taken at 570 nm and 655 nm. Experiments
were performed in triplicate and repeated three times.
RNA isolation and real-time PCR
Total cellular RNA was isolated from SMCs using an
RNeasy Mini Kit (Qiagen) according to the manufac-
turer’s instructions. RNA was subjected to reverse tran-
scription using Taqman reverse transcription kit (Applied
Biosystems) following the manufacturer’s instructions.
Real time PCR amplifications were performed using
iQTM SYBR Green supermix (BIO-RAD). The relative
quantities of mRNAs were obtained by using the compara-
tive Ct method and were normalized with glyceraldehydes-
3-phosphate dehydrogenase (GAPDH). Primers sequences
for FHC were: forward 5′-ATTTCCCCATAGCCGTG -3′,
reverse 5′-GCCTGGATAGATTTCTGATTC -3′.
The measurement of ROS accumulation
The intracellular ROS levels were detected by means of
an oxidation-sensitive fluorescent probe (DCFH-DA).
Briefly, the cells were cultured and treated with the indi-
cated time intervals. Then, the cells were harvested,
washed twice with PBS, incubated with DCFH-DA (1 μM)
in serum-free DMEM at 37°C in a 5% CO2 incubator for
20 minutes, washed twice with PBS and analyzed by Im-
munofluorescence microscope.
Transient transfection and identification of autophagy
Hep3B and SMMC-7721 cells were seeded (5 × 104 cells/
well) in 96-well plates for overnight, then GFP-LC3 ex-
pressing plasmids were transiently transfected into the
cells using Fugene HD transfection reagent (Roche) ac-
cording to the manu-facturer‘s instructions. After cul-
tured for 24 h to ensure the expression of GFP-LC3, the
cells were subjected to different treatment. At the end of
the treatment, autophagy was detected by counting the
percentage of cells with GFP-LC3-positive dots under
fluorescence microscope. Aminimum of 200 cells per
sample was counted in triplicate for each experiment.
Plasmid transfection
The site-specific, signal-induced degradation of IκBα de-
pends on phosphorylation at Ser 32 and 36. Therefore,
the pBαbe-SR-IκBα plasmid that consisted of a double
point mutation (Ser to Lactamine) was thus resistant to
phosphorylation. The mutant and control plasmids were
transiently transfected into Hep3B and SMMC-7721 cells
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moved by trypsin/EDTA treatment and seeded at a density
of 2x105 cells/ml in 6-cm culture dishes. Cells were grown
to 90% confluence and subjected to 24-h synchronization
in serum-free medium. Hep3B and SMMC-7721 cells were
transfected with 4 μg of the pBαbe-SR-IκBα or control
pBαbe plasmid per dish with the use of Lipofectamine.
After incubation for 6 h, the transfection medium was re-
placed by fresh medium for an additional 48-h incubation
to allow for gene expression to occur.
Short hairpin RNA
shRNA candidate target sequences to Beclin1 is 5′-
GCAGATGAGGAAGATCGCCTT-3′. The oligonucleo-
tides encoding the shRNA sequence were inserted into the
GFP express vector pGCL-GFP (Shanghai GeneChem,
shanghai). SCR-shRNA was used as a negative RNAi
control. The recombinant virus was packaged using
Lentivector Expression Systems (Shanghai GeneChem).
Apoptosis assays
Hep3B and SMMC-7721 cells were plated (1 × 106 cells/
well) onto 6-well plates for overnight in incubator to
resume exponential growth. At the end of the various
treatment, every sample were removed from the medium
and washed with PBS twice. Then the cells were stained
with FITC-conjugated Annexin V and propidium iod-
ide (PI), using Annexin V-FITC Apoptosis Detection
kit and according to manufacturer‘s recommendation
(Calbiochem). Flow cytometry (BD Biosciences, USA) was
used to determine the percentage of apoptotic cells.
NF-κB-dependent reporter gene assay
NF-κB luciferase reporter assays were performed as de-
scribed previously [14]. Briefly, cells were co-transfected
with a pNF-κB-luc reporter construct and a renilla
luciferase-expressing plasmid (internal control to nor-
malize for transfection efficiency) using Lipofectamine
2000 according to the manufacturer’s instructions. At
the end of the various treatment, firefly and renilla lucif-
erase activities were assessed using a dual luciferase re-
porter gene assay kit. NF-κB transcriptional activity =
relative light units of firefly luciferase/relative light units
of renilla luciferase.
Immunofluorescence
Immunofluorescence staining was performed according
to standard protocol (Santa Cruz Biotechnology). Hep3B
and SMMC7721 cells were seeded (1 × 105 cells/well) on
a 48-well plate, cultured in DMEM without FBS and
Antibiotic for 6 h, and 3-MA was added to the cell cul-
ture at the same time. Then cells were treated with or
without TNF-α (10 ng/ml) for 24 h, then the cells were
washed twice with PBS, and fixed in 4% paraformaldehydeand 0.1% Triton X 100 in PBS buffer at 4°C for 30 minutes.
After being washed with PBS, the cells were incubated
with the blocking solution (10% goat serum in PBS), and
then incubated overnight with the primary antibodies,
washed with PBS, and finally incubated with secondary
antibodies at 37°C for 2 hours. After being stained with
DAPI, all matched samples were photographed using an
immunofluorescence microscope and identical exposure
times.
Statistical analysis
All the experiments were performed at least three times.
Student’s t-test was used for all the statistical analyses,
and the differences were considered significant if the
p value was less than 0.05.
Results
TNF-α attenuated serum starvation-induced apoptosis
in Hep3B and SMMC-7721 cells
Five different concentrations of TNF-α and two different
serum settings (serum-cultured and serum-deprived)
were used to investigate the effects of TNF-α on the
cell viability and apoptosis of Hep3B and SMMC-
7721 cells. We performed a cell viability assay, TNF-α did
not significantly affect the cell viability of serum-cultured
Hep3B and SMMC-7721 cells up to 100 ng/ml, which
significantly suppressed the cell viability of serum-
cultured and serum-deprived cells. Interestingly, low-
dose TNF-α (0.1, 1 and 10 ng/ml) prevented the loss
of cell viability of serum-deprived cells, especially in
the 10 ng/ml TNF-α group (Figure 1A and 1B). This
concentration was therefore used to evaluate the effect of
TNF-α on serum starvation-induced cell death of Hep3B
and SMMC-7721 cells. Following 6 hour ‘pre-starvation’,
cells were incubated with TNF-α for 0 h to 48 h and cell
viability was detected by MTT. At 0 h and 12 h, there
was no significant difference between the cell viabil-
ity of serum starvation + TNF-α group and that of
serum starvation group; at 24 h and 48 h, the cell
viability of serum starvation + TNF-α group was sig-
nificantly higher than that of serum starvation group
(Figure 1C and 1D). Flow cytometry analysis revealed
that the percentage of apoptosis Hep3B and SMMC-
7721 cells in the serum starvation + TNF-α group sig-
nificantly decreased (3.51% ± 1.21% vs 12.12% ±
1.42% ; 4.88% ± 1.02% vs 17.33% ± 1.31%, P < 0.01)
compared with the serum starvation group; there
were no significant differences between the control
and TNF-α groups of serum-cultured Hep3B and
SMMC-7721 cells (1.16% ± 0.54% vs 1.02% ± 0.45%;
1.46% ± 0.64% vs 1.53% ± 0.65%, P > 0.05, Figure 1E).
These results indicate that TNF-α attenuates serum
starvation-induced apoptosis in Hep3B and SMMC-
7721 cells.
Figure 1 TNF-α attenuated serum starvation-induced apoptosis in Hep3B and SMMC-7721 cells. (A, B, C and D) Cell activity were
detected by MTT analysis. Hep3B (A) and SMMC-7721 (B) cells were treated with or without 6 h pre-treatment of serum starvation (that is
nutrient- and serum-free medium), then treated with TNF-α (0, 0.1, 1, 10, 100, 1000 ng/ml) for 24 h. Hep3B (C) and SMMC-7721 (D) cells were
treated with 10 ng/ml TNF-α for 12, 24 and 48 h with 6 h pre-treatment of serum starvation. (E) Cells were cultured in medium with or without
10% FBS for 6 h, then treated with or without 10 ng/ml TNF-α for 24 h. Flow cytometry was used to test cell apoptosis rate. Data represent the
mean ± SEM of three independent experiments. **P < 0.01; Student’s t-test.
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Figure 2 3-MA attenuated TNF-α protection against serum starvation-mediated apoptosis. Hep3B and SMMC-7721 cells were cultured
under serum starvation condition for 6 h, and 3-MA was added to the cell culture at the same time. Then cells were treated with or without TNF-α
(10 ng/ml) for 24 h. (A and B) Total cellular protein (50 μg) was separated by SDS-PAGE and immunoblotted for P62, LC3 and GAPDH. (C) Cells were
transfected with GFP-LC3 for 24 h before they were treated with serum starvation. At the end of treatment, the cells were examined by fluorescence
microscopy. (D and E) Cell activity was determined by MTT analysis. (F and G) Apoptosis was measured by flow cytometry. Data are presented as the
mean ± SEM from three independent experiments. **P < 0.01; Student’s t-test.
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against serum starvation-mediated apoptosis
To investigate whether autophagy signaling pathway was
related to the effect of TNF-α, its inhibitor 3-MA ad-
ministered prior to TNF-α treatment. Western blotting
analysis showed that serum starvation resulted in an
increase in LC3II and a decrease in P62, however,
the treatment of 3-methyladenine reversed the change
(Figure 2A and 2B). Meanwhile, 3-MA reduced the GFP-
LC3 dot aggregation, as well as the LC3II protein on
western blotting (Figure 2C). After treatment of TNF-α,
the cell viability of serum starvation + TNF-α group was
significantly higher than that of serum starvation group.
However, when the cells were grown in the presence of
TNF-α and 3-MA, 3-MA blocked the effect produced by
TNF-α. There were no significant differences between
the 3-MA and 3-MA + TNF-α groups of serum-deprived
cells (Figure 2D and 2E). To further confirm the results
from our MTT data, we used Annexin V-PI staining.
Flow cytometry analysis showed that treatment with
TNF-α decreased the population of apoptotic cells,
while treatment with TNF-α + 3-MA increased the
population of apoptotic cells. There were no significant dif-
ferences between the 3-MA and 3-MA+TNF-α groups
(Figure 2F and 2G). In addition, we inhibited autophagy by
shRNAs to Beclin1, and obtained similar results with
3-MA (Additional file 1: Figure S1). These results demon-
strate that autophagy conferred the TNF-α protection
against serum starvation-mediated apoptosis of hepatocel-
lular carcinoma cells.
3-MA suppressed TNF-α-induced NF-κB transactivation
Previous studies have shown that NF-κB is a powerful
transcription factor that blocks apoptosis [15]. TNF-α
can induce NF-κB transactivation via IκB kinase (IKK)
complex phosp orylation, which lead to degradation of
IκBs and the consequent translocation of NF-κB to nu-
cleus [9,10,16,17]. We examined TNF-α mediated NF-κB
transactivation in Hep3B and SMMC-7721 cells. The ex-
pression levels of representative upstream and down-
stream signaling proteins involved in NF-κB activation
were detected by Western blotting analysis. Hep3B and
SMMC-7721 cells were cultured under serum starvation
condition in the presence or absence of 3-MA for 6 h, then
cells were treated with or without TNF-α (10 ng/ml) for
24 h. After treatment of TNF-α, a significant increaseprotein expressions of NF-κB p65 was observed, while
TNF-α decreased protein expressions of IκBα. Interest-
ingly, 3-MA reversed the effect of TNF-α (Figure 3A
and 3B). Hep3B and SMMC-7721 cells were stimulated
with TNF-α in the presence of 3-MA for the indicated
times (hours). It showed that TNF-α resulted in the rapid
loss of IκBα expression in cells, which was followed by its
re-expression 1 hour later (Figure 3C and 3D). The rapid
activation may be attributed to the control of proteasome
as described in the article [18]. To further confirm the re-
sults from the western blotting, we performed a NF-κB-
dependent reporter gene assay. It showed that TNF-α
treatment resulted in a significant increase of luciferase ac-
tivity in Hep3B and SMMC-7721 cells, while 3-MA re-
versed this change (Figure 3E and 3F). In addition, NF-κB
nuclear translocation was assessed by immunofluorescence
staining for NF-κB p65. The green nuclear signal was an
indication of the activation. TNF-α significantly increased
p65 subunit translocation, however, 3-MA suppressed the
translocation of p65 subunit (Figure 3G). These results
showed that 3-MA significantly suppressed NF-κB activity
induced by TNF-α (P < 0.05), which indicated that autoph-
agy conferred the TNF-α-induced NF-κB activation.
NF-κB inhibitor BAY11-7082 inhibited TNF-α protection
against serum starvation-mediated apoptosis
Because serum starvation-induced apoptosis was inhibited
by TNF-α, which enhanced the transactivation of NF-κB,
it suggested a link between NF-κB transactivation and
inhibition against serum starvation-induced apoptosis. To
determine whether NF-κB transactivation is important in
TNF-α protection against serum starvation-induced apop-
tosis, we used BAY11-7082 to inhibit NF-κB transactiva-
tion in Hep3B and SMMC-7721 cells. After treatment of
TNF-α with BAY11-7082, the percentage of apoptosis cells
significantly increased compared with the TNF-α group;
there were no significant differences between the BAY11-
7082 group and TNF-α + BAY11-7082 group (Figure 4A
and 4B). Moreover, western blotting showed that TNF-α
inhibited expression of caspase-8 and cleaved caspase-3,
but these were reversed by BAY11-7082 (Figure 4C
and 4D). Furthermore, the mutant plasmids were tran-
siently transfected into Hep3B and SMMC-7721 cells
by Lipofectamine to inhibit the activation of NF-κB,
and obtained similar results with BAY11-7082 (Additional
file 1: Figure S2). These results indicated that TNF-α
Figure 3 (See legend on next page.)
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Figure 3 TNF-α induced NF-κB activation and 3-MA attenuated the activation of NF-κB. Hep3B and SMMC-7721 cells were cultured under
serum starvation condition for 6 h, and 3-MA was added to the cell culture at the same time. Then cells were treated with or without TNF-α
(10 ng/ml) for 24 h. (A and B) Total cellular protein(50 μg) was separated by SDS-PAGE and immunoblotted for IκBα, P65 and GAPDH.
(C and D): Hep3B and SMMC-7721 cells were stimulated with TNF-α in the presence of 3-MA for the indicated times (hours). Western boltting was
performed with anti-IκBα. (E and F) Cells were transduced using an NF-κB luciferase construct, then the cells were treated according to the
previously described steps. At the end of the various treatment, firefly and renilla luciferase activities were assessed using a dual luciferase reporter
gene assay kit. (G) NF-κB nuclear translocation was assessed by immunofluorescence staining for NF-κB p65 (green), cell nuclei were detected by
DAPI (× 400). The percentage of the p65 nuclei-positively stained cells to the total cells was quantified. Data are presented as the mean ± SEM from
three independent experiments. **P < 0.01; Student’s t-test.
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starvation-induced apoptosis via transactivation of
NF-κB.
Overexpression of FHC induced by TNF-α inhibited
apoptosis signaling in serum-deprived cells
It has been known NF-κB can regulate the expression of
the anti-apoptotic gene products, including IAPs [19,20],Figure 4 NF-κB inhibitor BAY11-7082 decreased TNF-α protection aga
and SMMC-7721 cells were cultured with TNF-α (10 ng/ml) and/or BAY11-7
was performed to detect the apoptosis. Data are presented as the mean ±
(C and D) Expression of caspase-8 and cleaved caspase-3 were determinedBcl-2 [21], Bcl-xL [22-24], Mcl-1, TRAF-1 [25], Survivin
and FHC [26]. FHC is upregulated by TNF-α through
activation of NF-κB, is essential to inhibit apoptosis in
NF-κB null cells [26]. Western blotting and RT-PCR
analysis showed that TNF-α treatment increased the ex-
pression of FHC compared with control group, this was
inhibited by BAY11-7082 (Figure 5A and 5B). To deter-
mine whether the induction of FHC by NF-κB serves ainst serum starvation-mediated apoptosis. Serum-deprived Hep3B
082 (10 μM). (A and B) Cells were harvested at 24 h, FITC/PI staining
SEM from three independent experiments. **P < 0.01; Student’s t-test.
by Western blotting.
Figure 5 (See legend on next page.)
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Figure 5 Overexpression of FHC induced by TNF-α inhibited apoptosis signaling in serum-deprived cells. (A and B) Serum-deprived
Hep3B and SMMC-7721 cells were cultured with or without TNF-α (10 ng/ml) and/or BAY11-7082 (10 μM). The expression of FHC was determined
by RT-PCR and Western-blotting analysis. Hep3B (C) and SMMC-7721 (D) cells were transfected with siFHC or Vector and then serum-deprived cells were
treated with or without TNF-α (10 ng/ml) for 24 h. Western blotting was performed with anti-FHC or anti-caspase-8 or anti-cleaved caspase-3 or GAPDH.
(E and F) Cell viability was detected by MTT assay. (G and H) Cells were harvested and stained with Annexin-V-FITC and PI, apoptosis was measured by
flow cytometry. Data are presented as the mean ± SEM from three independent experiments. **P < 0.01; Student’s t-test.
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cells by small interfering RNA (siRNA). After treat-
ment of TNF-α, the expression of caspase-8 and
cleaved caspase-3 in cells transfected with siFHC was
increased compared with that transfected with vector
siRNA (Figure 5C and 5D). Consistent with the results
obtained by western blotting, cell viability of TNF-α +
siFHC group was reduced compared with TNF-α + vector
group (Figure 5E and 5F). And, fluorescence microscopy
showed that the population of apoptotic cells was de-
creased by TNF-α treatment, while this was inhibited by
TNF-α + siFHC treatment (Figure 5G and 5H). These re-
sults suggested that the induction of FHC by NF-κB is re-
quired to suppress serum starvation-induced apoptosis.
ROS inhibition by FHC protected cells from serum
starvation-induced apoptosis
ROS plays an important role in the induction of apop-
tosis by serum starvation. To determine whether the
induction of FHC inhibited serum starvation-induced
apoptosis via ROS inhibition, we used siRNA to block
FHC expression. DCF fluorescence showed that TNF-α
significantly decreased the level of intracellular ROS, how-
ever, siFHC treatment reversed this change (Figure 6A).
Treatment with NAC (a ROS scavenger) suppressed TNF-
α-induced caspase cascade inhibition (Figure 6B). These
results indicated that FHC inhibited serum starvation-
induced apoptosis via ROS inhibition.
Discussion
TNF-α is an extraordinarily pleiotropic cytokine pro-
duced mainly by activated macrophages and a few by
several other types of cell [27,28]. Under normal physio-
logical conditions TNF-α plays a part in maintenance
and homeostasis of host defence and the immune sys-
tem; on the other side, its “inappropriate” overexpression
is implicated in malignant disease and pathological in-
jury, such as insulin resistance, autoimmunity, septic
shock, allergy and allograft rejection [28,29]. TNF-α is
well known for the anticancer properties and is being an
effective anticancer agent for the treatment of patients
with locally advanced solid tumors [29]. However, TNF-α
is a double-edged sword for cancer. TNF-α could be an en-
dogenous tumor promoter in tumor microenvironment,
because TNF-α stimulates cancer cells’ growth, prolifera-
tion, invasion and metastasis, and tumor angiogenesis[30-32]. It is of significance to research the relationship
between TNF-α and HCC, which is one of the 10 most
common human carcinomas in the world. Past studies
have shown that TNF-α contributes to liver carcinogen-
esis early in the preneoplastic phase through driving oval
cell proliferation [33]. In the model of p-glyco-protein 2
(Mdr2)-knockout mice, TNF-α and the activation of
NF-кB accelerated the process of tumor in the occur-
rence of HCC [34]. In our study, it is consistent with
previous studies [4,29], high doses of TNF-α (100 or
1000 ng/ml) enhanced serum starvation-induced apop-
tosis, which maybe due to the direct killing effect of
TNF-α on tumor cells. Interestingly, low doses of TNF-α
(0.1, 1 and 10 ng/ml) attenuated serum starvation-
induced apoptosis, especially in the 10 ng/ml TNF-α group
(Figure 1). The results suggested that TNF-a may play an
important role in HCC survival.
In the present study, we examine the TNF-α effect on
serum starvation-mediated apoptosis of HCC cells in
light of the potential importance of TNF-α in HCC sur-
vival, we examine whether the TNF-α effect on serum
starvation-induced apoptosis of HCC cells via autophagy.
Autophagy can also be considered a temporary survival
mechanism during periods of serum starvation where self-
digestion provides an alternative energy source and also
may facilitate the disposal of unfolded proteins under stress
conditions [35]. Autophagy has a dynamic role in cancer—
both as a tumor suppressor early in progression and later
as a protumorigenic process, critical for tumor mainten-
ance and therapeutic resistance [36-38]. Evolving tumors
develop regions of hypoxia and nutrient limitation, where
elevated autophagy activation has been found previously to
promote tumor survival. Moreover, the role for the TNF-α-
induced NF-κB pathway in autophagy was supported by
the evidence that the IKK complex was necessary for the
stimulation of autophagy by several factors [18,39,40].
Therefore, it is necessary to examine whether the TNF-α
effect on serum starvation-induced apoptosis of HCC cells
via autophagy. In the present study, we showed that
3-Methyladenine (3-MA) attenuated TNF-α protection
against serum starvation-mediated apoptosis (Figure 2).
This suggested that autophagy conferred the TNF-α pro-
tection against serum starvation-mediated apoptosis.
In our study, Pre-induction of cells with the pharma-
cological inhibitor-Bay11-7082, inhibited NF-κB trans-
activation, attenuated TNF-α protection against serum
Figure 6 ROS inhibition by FHC protected cells from serum starvation-induced apoptosis. Hep3B and SMMC-7721 cells were transfected
with siFHC or Vector and then serum-deprived cells were treated with or without TNF-α (10 ng/ml) for 24 h. (A) The formation of reactive oxygen
species (ROS) was assayed by measuring the fluorescence of dichlorofluorescein (DCF). (B) Serum-deprived Hep3B and SMMC-7721 cells were cultured
with or without TNF-α (10 ng/ml) and/or N-acetylcysteine (NAC) (10 mM). The expression of pro/active-caspase-8 and pro/active- caspase-3 were
determined by Western-blotting analysis. (C) and (D): Serum-deprived Hep3B and SMMC-7721 cells were cultured with or without TNF-α (10 ng/ml)
and/or N-acetylcysteine (NAC) (10 mM).Flow cytometry was used to test cell apoptosis rate. Data are presented as the mean ± SEM from three
independent experiments. **P < 0.01; Student’s t-test.
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cells. Our results suggested that TNF-α induced transacti-
vation of NF-κB in favor of survival or anti-apoptotic sig-
naling in Hep3B and SMMC-7721 cells (Figure 3 andFigure 4). Ferritin heavy chain (FHC) is one of the NF-κB-
regulated genes that counteract apoptotic signaling by
TNF-α in a number of cells [26]. It is identified that FHC
as a pivotal effector of the antioxidant and protective
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http://www.biomedcentral.com/1471-2407/13/438actions of NF-κB downstream of TNF-Rs [41]. FHC is
upregulated by TNF-α through a mechanism controlled
by NF-κB, which is required for inhibition of TNF-α-in-
duced killing and blocking PCD in NF-κB-deficient cells
[26]. FHC is one of several acute-phase proteins, induced
in the liver during the organismal response to stress, in-
jury and infection. FHC might also play a prominent role
in NF-κB-dependent oncogenesis, tumor progression and
cancer chemo- and radio-resistance. High levels of FHC
have in fact been found in several tumors and have been
associated with resistance to anti-cancer treatment and
an aggressive malignant phenotype [42]. In our Hep3B
and SMMC-7721 cells, FHC was present at very low de-
tectable level endogenously, but increased significantly
24 h after TNF-α treatment. The kinetics of TNF-α-in-
duced FHC expression was directly correlated with kinetics
of TNF-α protection against serum starvation-induced
apoptosis in Hep3B and SMMC-7721 cells. In order to
confirm that FHC contributes to apoptosis resistance in
Hep3B and SMMC-7721 cells, we suppressed FHC expres-
sion in the cells by small interfering RNA (siRNA) and
assayed their apoptosis sensitivity. Apoptotic cell popula-
tion in Hep3B and SMMC-7721 cells transfected with
FHC siRNA was larger than that transfected with control
siRNA at concentration of 10 ng/ml TNF-α exposure
(Figure 5). These results suggested that FHC prevents
apoptosis induced by serum starvation.
The observation that FHC protected HCC cells from
serum starvation-induced apoptosis prompted us to in-
vestigate whether FHC mediated the inhibition of ROS
by serum starvation. Human mesothelial cells stably
over-expressing FHC generated less H2O2 when chal-
lenged by asbestos and were resistant to apoptosis in-
duced by oxidant stimuli compared with control cells
[43]. It suggested FHC reduced intracellular oxidative
stress triggered by asbestos exposure in mesothelial cells
and contributes to apoptosis resistance by diminishing
ROS generation. Our results are consistent with the re-
sults obtained by others, using Hep3B and SMMC-7721
cells. Recently, it is reported the key role of FHC in regu-
lating apoptosis during inflammation. They showed that
FHC was required to prevent sustained c-Jun N-terminal
kinase cascade activation, thus inhibiting apoptosis induced
by TNF-α. FHC-driven inhibition of c-Jun N-terminal kin-
ase signaling depends on suppressing ROS generation and
is achieved through kllits ability to sequester iron. Our re-
sults showed HCC cells over-expressing FHC generated
less ROS when challenged by TNF-α and were resistant to
apoptosis induced by serum starvation. These results sug-
gested that autophagy conferred the TNF-α protection
against starvation-mediated apoptosis of hepatocellular
carcinoma cells, the process involved with transactivation
of NF-κB, up-regulation of anti-apoptotic FHC, reactive
oxygen species and caspase suppression. Understandingthe contribution of TNF-α-mediated cell survival may
be relevant to the therapy of hepatocellular carcinoma.
Conclusion
Our findings suggested that autophagy conferred the
TNF-α protection against serum starvation-mediated
apoptosis of hepatocellular carcinoma cells, the process
involved with transactivation of NF-κB, up-regulation of
anti-apoptotic FHC, suppression of reactive oxygen spe-
cies and caspase.
Additional file
Additional file 1: Figure S1. Inhibition autophagy with shRNA not only
attenuated TNF-α protection against serum starvation-mediated apoptosis
but also decreased the activation of NF-κB. Hep3B and SMMC-7721 cells
were treated with serum starvation, after 6 h cells were transfected with
shRNA against the essential autophagy Beclin1. Then cells were treated with
or without TNF-α (10 ng/ml) for 24 h under serum starvation condition.
(A and B) Shown is a representative Western blot comparing Beclin1
expression with a control shRNA. The bottom panel is a GAPDH
loading control. (C and D) Cell activity was determined by MTT analysis.
(E and F) Apoptosis was measured by flow cytometry. (G and H) Cells
were transduced using an NF-κB luciferase construct, then the cells were
treated according to the previously described steps. At the end of the
various treatment, firefly and renilla luciferase activities were assessed
using a dual luciferase reporter gene assay kit. Data are presented as the
mean ± SEM from three independent experiments. **P<0.01; Student’s
t-test. Figure S2. Inhibition of NF-κB inhibited TNF-α protection and
the FHC expression. Serum-deprived Hep3B and SMMC-7721 cells
were cultured with TNF-α (10 ng/ml) and/or pBαbe/pBαbe-SR-IκBα.
(A and B) Expression of IκBa protein following pBabe-SR-IκBa plasmid
transfection, demonstrated by western blot analysis. (C and D) Cells
were harvested at 24 h, FITC/PI staining was performed to detect the
apoptosis. (E and F) The expression of FHC was determined by RT-PCR
and Western-blotting analysis. Data are presented as the mean ± SEM
from three independent experiments. **P<0.01; Student’s t-test.
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